Valeant Pharmaceuticals

Page 4 of 4

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Valeant under federal investigation for how it prices drugs

By
October 15, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Biotech stocks dive as lawmakers take aim at Valeant for drug price hikes

By
September 28, 2015
Valeant had the hots for ‘female Viagra,’ Sprout CEO says
MPW

Valeant had the hots for ‘female Viagra,’ Sprout CEO says

By
August 20, 2015
Flibanserin
Health

Valeant snaps up ‘Female Viagra’ maker Sprout for $1 billion

By
August 20, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
Finance

The real reasons for the pharma merger boom

By
July 28, 2015
157934085
Finance

Teva in talks to buy Allergan’s generic drug business

By
July 26, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

Endo International makes competing bid for Salix Pharmaceuticals

By
March 11, 2015
IL: Corporations In Illinois
Finance

Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever

By
February 6, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By
January 31, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Zoetis shares spike on reported Ackman stake purchase

By
November 11, 2014
Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

By
October 30, 2014
Botox
Finance

SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan

By
August 14, 2014
Morgan Stanley caught playing both sides of Allergan-Valeant fight
Finance

Morgan Stanley caught playing both sides of Allergan-Valeant fight

By
June 16, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance

Valeant injects more cash into bid for Botox-maker Allergan

By
May 30, 2014
Fortune

Valeant ready to beef up bid for maker of Botox

By
May 13, 2014

Most Popular